Author Correction: Oncolytic T-VEC virotherapy plus neoadjuvant chemotherapy in nonmetastatic triple-negative breast cancer: a phase 2 trial.
Soliman H, Hogue D, Han H, Mooney B, Costa R, Lee MC, Niell B, Williams A, Chau A, Falcon S, Soyano A, Armaghani A, Khakpour N, Weinfurtner RJ, Hoover S, Kiluk J, Laronga C, Rosa M, Khong H, Czerniecki B.
Soliman H, et al. Among authors: laronga c.
Nat Med. 2023 Dec;29(12):3270. doi: 10.1038/s41591-023-02309-4.
Nat Med. 2023.
PMID: 36932246
No abstract available.